Since 2021, shares of Novavax (NVAX 12.02%) have absolutely crumbled, falling by a whopping 95%. Even with the price rally in recent days, the stock has still been a disastrous investment over the past few years. The price drop was justified largely because the company's fate was uncertain. There were question marks relating to its growth and a canceled purchase agreement. The good news is that one of those issues recently reached a positive resolution. Is that enough to make this beaten-down stock worth ta ...